Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-β and tumor necrosis factor-α in endothelial cells

Thrombosis and Haemostasis

Volumn 86, Issue 6, 2001, Pages 1563-1572

  Chen, Y Q ^a   Sloan Lancaster, J ^a   Berg, D T ^a   Richardson, M A ^a   Grinnell, B ^a   Tseng Crank, J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Endothelium; MAP kinase; Plasminogen activator inhibitor 1; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITOR; SMAD PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

5' UNTRANSLATED REGION; ANIMAL CELL; AORTA; ARTICLE; CATTLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE LOCATION; HALF LIFE TIME; HEMOSTASIS; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RECEPTOR UPREGULATION; RISK FACTOR; RNA STABILITY; SIGNAL TRANSDUCTION; THROMBOSIS; TRANSCRIPTION REGULATION;

EID: 0035657775     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616763     Document Type: Article

References (30)

1. The status of plasminogen activator inhibitor-1 as a therapeutic target
2. Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1
3. PAI-1 inhibits neointimal formation after arterial injury in mice: A new target for controlling restenosis?
4. The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease
5. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock
6. The transcriptional program in the response of human fibroblast to serum
7. Structure-function relationships in serpins: Current concepts and controversies
8. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene
9. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor muE3, and Smad proteins
10. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation
11. TGF-beta signal transduction
12. Smads as transcriptional co-modulators
13. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression
14. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling
15. Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity
16. TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism
17. Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family
18. Role of Ras and MAPKs in TGF-beta signaling
19. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein
20. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha
21. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
22. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
23. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
24. Human Smad3 and Smad4 are sequence-specific transcription activators
25. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription
26. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells
27. A mechanism of suppression of TGF-beta/SMAD signaling by NK-kappa B/Re1A
28. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
29. Cyclic nucleotide regulation of type-1 plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. Identification of cis-acting sequences
30. Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells